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ABSTRACT
Continuous ambulatory peritoneal dialysis (CAPD) is the prevailing mode of renal replacement
therapy in Hong Kong and the routine practice is three 2 L daily exchanges with four exchanges
reserved for patients with ultrafiltration problems or clinically inadequate dialysis. In our hospital,
Tung Wah Hospital, adequacy of dialysis assessment by urea kinetics was conducted after 1993
and adjustment of dialysis regime according to Kt/V was made only after 1995. This study
represented the survival data of CAPD patients in our center before the urea kinetics era. From
1983 to 1994, we have accepted 569 patients into our CAPD program with a mean age +SD of 47.8
+15.4 and incidence of diabetes of 17.9%. The overall patient survival rates were 92%, 56% and
26% at 1, 5 and 10 years respectively. The corresponding technique survival rates were 97%, 86%
and 60%. A cross-sectional analysis of the CAPD population from 1993 to 1994 showed that only
5% of patients were on four 2 L exchanges and the mean Kt/V was 1.76 +0.35 and creatinine
clearance 58.1 +23.2 L/week/1.73 m2. The patient and technique survival rates were comparable
to western centers with a higher mean Kt/V and creatinine clearance. Our data showed that
favorable clinical outcome can be achieved with three 2 L daily exchange regime in Chinese patients.
This indicates different Kt/V standards may exist for different racial populations.
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INTRODUCTION
Since the introduction of continuous ambulatory
peritoneal dialysis (CAPD) by Popovich and Moncrief
in 1977, CAPD has been widely accepted as a mode of
replacement therapy for end-stage renal failure (ESRF)
patients. The initial dialysis regime proposed by
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Popovich and Moncrief for a standard anuric white
patient of 70 kg body weight was four 2 L daily
exchanges (1). This regime was soon adopted as the
standard dialysis regime for CAPD across the world until
recently when the issue of tailor-made dialysis
prescription according to dialysis adequacy assessment
with urea kinetics (Kt/V) was raised. CAPD was
introduced into Hong Kong in 1980 and soon became
the predominant form of renal replacement therapy. Over
70% of patients with ESRF were treated with CAPD.
For social and economical reasons, three 2 L daily
exchanges were adopted as the standard treatment
regime. Four exchanges would only be prescribed for
patients with inadequate ultrafiltration or clinical
underdialysis. CAPD program was started in our center
in 1983 and not until 1995 was the patients' treatment
regime adjusted according to urea kinetic modeling. We
hereby report the clinical outcome in terms of patient
and technique survival rates of our patients who received
a basic three 2 L daily CAPD exchange regime in this
pre-urea kinetic era.
METHODS
From 1983 to 31 December 1994, we have accepted 569
patients into our dialysis program. Records of all patients
were retrieved to obtain relevant clinical data on patient
and technique survival. Kaplan-Meier life-table analysis
and Mantel-Haensel test were used to analyze the survival
rates according to gender, diabetic status and age. Patients
were divided into four groups according to age at
commencement of CAPD (group I: age <35; group II:
35-50; group III: 50-65 and group IV: >65). The
censoring date was 30 June 1995. Censoring events for
patient survival included transfer to hemodialysis (HD),
successful renal transplantation, transfer to other units
or loss of follow-up. In addition to the conventional
method of calculating technique survival which only
counts transfer to HD as an event, we also included death
related to peritoneal dialysis (PD) complications (PD
related deaths) which included peritonitis, fluid overload,
underdialysis and withdrawal of dialysis for social
reasons as events of technique failure. Peritonitis rates
during the period were calculated for the whole
population.
Adequacy of dialysis assessment was introduced in our
center in 1993. In order to assess the dialysis adequacy
status in our patients treated with routine dialysis regime,
the first assessment performed in 1993 to 1994 for each
existing patient was analyzed cross-sectionally. Kt/V,
creatinine clearance (CrCl) and normalized protein
catabolic rate (nPCR) according to Randerson (2) were
estimated from 24-hour dialysate and urine collection.
Peritoneal equilibration test (PET) had been performed
in our unit since 1990 on a yearly basis. The peritoneal
transport rate was classified into high, high average, low
average and low transport according to Twardowski (3).
Values of all patients assessed in the year 1993 were used
to represent the distribution of peritoneal transport rates
of our dialysis population.
RESULTS
Among the 569 patients, there were 289 male and 280
female patients. The mean age at commencement of
CAPD was 47.8 +15.4 (range 13.6-84.2). It was 38.6 in
1983 and gradually increased to 55.8 in 1994. The
underlying renal disease was glomerulonephritis in 119
patients (including nine due to systemic lupus
erythematosus), diabetic nephropathy in 101 (17.8%),
hypertensive nephropathy in 28, chronic pyelonephritis
or reflux nephropathy in 22, polycystic kidney disease
in 15, obstructive uropathy in seven, miscellaneous in
seven and unknown in 270 patients. The incidence of
diabetes among new cases increased from 13% in 1983
to 29.7% in 1994. Straight line systems, either spike or
luer lock, were used as the connection technique in
majority of patients (437 patients, 76.8%) followed by
ultraviolet systems in 62 patients (10.9%), "O-set"
(Baxter, Deerfield, IL, USA) in 39 patients, "Ultraset"
(Baxter, Deerfield, IL, USA) in 22 patients, heat
disinfection system in two patients and cyclic peritoneal
dialysis in three patients. Spike system was the only
system available before 1989. Ultraviolet systems and
"O-set" were introduced in 1989, and "Ultraset" in 1994.
By 30 June 1995, 209 patients died, 122 were
transplanted and 43 patients were transferred to
permanent HD with peritonitis being the reason of
transfer in 40 patients. The major causes of death were
cardiovascular diseases in 48 patients, cerebrovascular
diseases in 14, peritonitis in 14, various infections in
another 14, pulmonary edema from fluid overload in
eight, malignancy in seven, withdrawal of dialysis due
to social reasons in seven and miscellaneous causes in
11 patients. The cause of death was uncertain in 86
patients, mostly because they were found dead at home
or died in other hospitals in a minority of patients. Twelve
patients survived more than 10 years and two more than
12 years. The overall patient survival rate was 92% at 1
year, 70% at 3 years, 56% at 5 years and 26% at 10 years
(Fig. 1). The respective survival rates for diabetics were
84.3%, 38.4%, 20.3% and 0%, and non-diabetic patients
were 94.2%, 77.5%, 65.2% and 31.7% (p < 0.001) (Fig.
2). The patient survival rates of different age groups were
shown in figure 3. The 1, 3, 5 and 10 year survival rates
for group I patients were 95.6%, 88.4%, 84.3% and
84.3%, group II 96.7%, 84.1%, 72.9% and 43% (p <
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0.05 compared to group I), group III 91.6%, 62.2%,
44.6% and 10.1% (p < 0.001 compared to group II), and
group IV 86%, 41.8%, 19.5% and 0% (p < 0.001
compared to group III). There was no statistical
difference in the demographic data including age and
incidence of diabetes, and survival rates between male
and female patients (Table 1).
The overall technique survival rates including PD related
deaths were 97% at 1 year, 91% at 3 years, 86% at 5
years and 60% at 10 years (Fig. 1) whereas the
conventional technique survival rates were 98.4%,
94.5%, 91.2% and 72.9% respectively. There was no
difference in technique survival rates between diabetic
and nondiabetic patients (Fig. 4). Patients older than 65
years or younger than 35 years of age had significantly
lower technique survival rates when compared to the
middle age groups (group IV vs other groups: p < 0.01;
group I vs groups II and III: p < 0.05; group II vs group
III: p = ns) (Fig. 5).
Results of the 201 patients (85 male and 116 female)
assessed in the cross-sectional study on adequacy of
Figure 1. Actuarial patient survival rate, technique survival rate
which excludes death, and technique survival rate which includes
PD related death of all CAPD patients.
Figure 2. Actuarial patient survival rate of diabetics and
nondiabetics, p < 0.0001.
Figure 4. Technique survival rate which includes PD related
deaths of diabetics and nondiabetics, p = NS.
Figure 5. Technique survival rate which includes PD related
deaths of CAPD patients according to different age groups, p <
0.05 between < 35 and 35-50, p < 0.01 between 50-65 and > 65.
There was no statistical difference between 35-50 and 50-65.
Figure 3. Actuarial patient survival rate of CAPD patients
according to different age groups, p < 0.05 between age groups <
35 and 35-50, p < 0.0001 between 35-50 and 50-65, and between
50-65 and > 65.
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dialysis have been published partially earlier (4). The
mean age was 52.7 +13.7 Years and duration of CAPD
treatment was 39.2 +33.5 months. The mean body height
and weight were 1.56 +0.08 m and 53.8 +97.3 kg
respectively. All patients were using three 2 L daily
exchanges except one was using three 1.5 L exchanges
and 11 patients (5%) were using more than 6 L per day
(one 7.5 L and ten 8 L). Total weekly Kt/V was 1.76
+0.35 within which 1.57 +0.28 was contributed from the
dialysis process. CrCl was 58.1 +20.2 L/week/1.73m2.
The CrCl from dialysis was 45.2 +6.3 L/week/1.73m2.
The mean residual glomerular filtration rate from
averaged renal urea and CrCl was 0.87 +1.50 ml/minute.
The mean nPCR was 1.01 +0.21 g/kg/day. The mean
serum albumin level was 37.6 +5.4 g/L. Kt/V was less
than 1.7 in 87 patients (43%) and less than 1.5 in 53 of
them (26%). Kt/V and CrCl were significantly lower in
male patients who had bigger body size than that in
female patients (Table 1).
PET was performed in 197 patients in the year 1993.
The mean age was 51.1 +14.5 years and the mean
duration of CAPD was 40.2 +34.0 months. The mean
creatinine dialysate to plasma ratio (D/P creatinine) at 4
hours was 0.723 +0.105. Majority were in the high
average transport group (113 patients, 57.4%), followed
by low average (41 patients, 20.8%) and high transport
group (39 patients, 19.8%). There were only four patients
(2%) in the low transport group.
Peritonitis rates from 1983 to 1994 were shown in figure
6. There was a gradual improvement after 1989, probably
related to the gradual introduction of UV systems and
disconnect systems like "O-set" and later "Ultraset", but
the peritonitis rate with the spike system also improved
from below 12 patient-months/episode in mid 1980s to
around 16 to 20 in 1990s.
DISCUSSIONS
The cross-sectional analysis reflected a low prevalence
of usage of the standard four 2 L exchange regime in our
practice over the study period. As a direct result of this,
the mean total Kt/V and peritoneal Kt/V were
substantially lower than those reported in the literature
from centers adopting the standard regime, which ranged
from 1.82 to 3.0 for total Kt/V (5-8) and 1.8 to 2.14 for
peritoneal Kt/V (7,8), despite the fact that our patients
had a lower mean body weight. As Kt/V is commonly
believed to be predictive of patients' clinical outcome, a
poorer survival might be expected in our center, but this
was not the case. The reported patient survival rates in
the western world which adopted the standard four 2 L
exchange regime ranged from 60% to 75% at 3 years,
and 31% to 51% at 5 years (9-14), while they were 70%
and 56% in our center respectively.
Different case mix in different centers often makes the
comparison of patient survival difficult. Factors that
known to affect patient survival other than adequacy of
dialysis are age, presence of diabetes mellitus and
cardiovascular diseases (15,16). The mean age at entry
of the CAPD program was younger among our patients
than that quoted by other centers (9-14), but this does
not account for the good survival in our patients because
the age adjusted survival rates were still comparable
(9,10). One may argue for the good survival as a result
of strict acceptance criteria for dialysis in Hong Kong in
the 1980s. However, the good survival in the younger
age groups (less than 50) indicated that it could not be
simply explained by the selection bias as these patients
would rarely be rejected for dialysis. The incidence of
diabetes was 17.8% in our patient population whereas it
ranged from 11% to 29% in the quoted centers (9-14).
The survival rate adjusted according to diabetes status
was also similar to those reported (10,14,17,18). As it
Table 1. Cross-sectional demographic data and dialysis adequacy
parameters in 201 CAPD patients according to gender.
Male Female
Number of patients 85 116
Age 54.2 +38.0 51.6 +13.5
Duration of CAPD, months 38.2 +38.0 39.9 +34.6
Body weight, kg 58.4 +10.3 50.4 +7.7*
Total Kt/V 1.56 +0.31 1.90 +0.31*
Peritoneal Kt/V 1.36 +0.19 1.72 +0.23**
nPCR, g/kg/day 1.02 +0.21 1.00 +0.21
5 year survivala 56.2% 56.2%
10 year survivala 22.9% 20.2%
nPCR = protein catabolic rate normalized to crude body weight
   (*p < 0.01, **p < 0.001)
apatient survival rates represented a pooled analysis of 569 CAPD
   patients
Figure 6. Peritonitis rates from the year 1983 to 1994.
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was difficult to make an accurate assessment of the
prevalence of cardiovascular disease retrospectively,
survival rates adjusted for the presence of cardiovascular
disease could not be analyzed. Therefore it may be
possible that the high overall survival rate of our patients
is related to a lower prevalence of cardiovascular disease
in Chinese (19). It is interesting to note that male patients
did not have a lower survival rate than female patients
though their mean Kt/V was significantly lower due to
their bigger body size. It may further indicate the
limitation of Kt/V in predicting survival. If there is any
bias, it should be against male patients as the average
life span of men are lower than that of women in Hong
Kong and the incidence of cardiovascular disease is also
higher in men (20).
Technique failure was very low in our center. The 5-
year technique survival rate from the United States
National CAPD Registry was 52% (21) whereas it was
86.3% in our series. The best technique survival rate
published in the literature was 86% at 3 years (22). Yet
this rate is still lower than the 94.5% in our series (91%
if including PD related deaths). It is also interesting to
note that the technique survival rate was comparable
between diabetics and nondiabetics, and that it was lower
in the youngest and the oldest age groups. The high
technique survival rate was probably related to the
commitment to CAPD by both patients and staff, as HD
is not a readily available option in Hong Kong. There is
very limited resources for HD service in the public
hospitals as the Health Authority of Hong Kong regards
CAPD as a much more cost-effective renal replacement
therapy. Not infrequently, patients had to continue on
CAPD even after repeated peritonitis episodes provided
that their peritoneal membrane can still be used for
dialysis. Such a strategy would have resulted in a lower
technique failure rate compared to centers with unlimited
HD facility. We have therefore examined the technique
survival rate which also includes PD related deaths as
end points. Even taking into account of PD related deaths
incurred by our tight HD policy, the technique survival
rate in our center was still very high. There was quite a
substantial portion of death without well-defined cause.
These patients mostly died at home, and should probably
be regarded as sudden death related to cardiac events
rather than PD related death.
Peritonitis rate has a great impact on technique survival.
Our peritonitis rate was generally low. The peritonitis
rates in our center improved from 12 patient-months/
episode in 1984 to 20 to 24 in the early 90s. Though the
major improvement was due to the advent of disconnect
systems, our peritonitis rates for the spike system were
between 16 to 20 patient-months/episode whereas most
reported peritonitis rates for the spike system in the
western world were around 8 to 12 patient-months/
episode (23,24). While better technique compliance in
our Chinese patients might be a contributing factor, other
possible factors accounting for our low peritonitis rate
were less frequent break-in procedures associated with
the three exchanges regime and less impaired peritoneal
defense mechanism with longer dwell time of the three
daily exchanges regime (25).
One further advantage of the three daily exchange regime
is that it hinders the vocational aspect less when
compared with four exchanges. Our unpublished data
showed that two-third of our patients below age of 50
years were either actively employed or working. This
has a substantial positive impact on patients' psychosocial
well being and may result in a better clinical outcome.
The mean D/P creatinine at 4 hours by PET in our center
was 0.72, very close to the reported ratio of 0.71 in
another center in Hong Kong (26), and was significantly
higher than the mean value of 0.65 reported by
Twardowski (3). The so-called low transporters
according to Twardowski's data is uncommon in our
population. The pattern of distribution of the peritoneal
transport rates was shifted toward the high side in our
patients compared with that of the Caucasian population.
The distribution of low, low average, high average and
high transport rates was 2%, 20.8%, 57.4%, 19.8% in
our series and 6.7%, 31.7%, 46.2%, 15.3% in the
CANUSA study respectively (27). It has been reported
that the risk of mortality and technique failure increased
with peritoneal transport rate because of the associated
poor ultrafiltration and higher peritoneal protein loss (27).
The pattern of distribution of peritoneal transport rates
certainly could not explain our good survival in a
commonly understood way. Though high peritoneal
transport rate often results in ultrafiltration problems, it
may allow more middle molecule uremic toxins removal
which depends on the dwell time and permeability of
the peritoneal membrane more than the frequency of
exchanges. Keshaviah showed that the peritoneal
clearance of B12, a middle molecule marker, was only
7% lower with three daily exchanges compared to four
exchanges whereas the difference in urea clearance was
as much as 17% (28). It is therefore possible that the
good survival in our patients might have been contributed
by a higher middle molecule clearance from the higher
mean peritoneal transport rate of our patients.
These survival data represented the clinical outcome of
our center before the urea kinetic era and indicated that
this basic three 2 L daily CAPD regime can be carried
out in the Hong Kong Chinese population with good
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results. This echoes with the recent finding of a superior
survival in the Asian-American HD patients from the
analysis of the United States Renal Data System by
Daugirdas (29). The superior survival was not related to
their smaller body size but to other unconfirmed factors
like diet. It is possible that there exists a different Kt/V
target in the Orientals due to differences in body size,
dietary habits and existence of comorbidity. The Asian
countries should develop their own dialysis regime to
achieve the best result within their financial constrain in
the provision of dialysis service.
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